These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14615119)

  • 1. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    ten Cate H
    Lancet; 2003 Nov; 362(9395):1581; author reply 1582. PubMed ID: 14615119
    [No Abstract]   [Full Text] [Related]  

  • 2. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    Turpie AG; Bauer KA; Eriksson BI; Lassen MR
    Lancet; 2003 Nov; 362(9395):1582-3. PubMed ID: 14615120
    [No Abstract]   [Full Text] [Related]  

  • 3. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    Bounameaux H
    Lancet; 2003 Nov; 362(9395):1581; author reply 1582. PubMed ID: 14615118
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
    Lowe GD; Sandercock PA; Rosendaal FR
    Lancet; 2003 Aug; 362(9383):504-5. PubMed ID: 12932379
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of venous thromboembolism with fondaparinux.
    Priestley M
    N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11911134
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of venous thromboembolism with fondaparinux.
    Murashige N; Kami M
    N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11907297
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents.
    Iorio A
    J Thromb Haemost; 2004 Jul; 2(7):1055-7. PubMed ID: 15219186
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery.
    Eriksson BI; Bauer KA; Lassen MR; Turpie AG
    J Thromb Haemost; 2003 Feb; 1(2):383-4. PubMed ID: 12871516
    [No Abstract]   [Full Text] [Related]  

  • 9. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery.
    Vormfelde SV
    Lancet; 2002 Nov; 360(9346):1701; author reply 1702. PubMed ID: 12457831
    [No Abstract]   [Full Text] [Related]  

  • 11. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
    Eriksson BI; Bauer KA; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1298-304. PubMed ID: 11794148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
    Turpie AG
    Int J Clin Pract; 2004 May; 58(5):483-93. PubMed ID: 15206506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomics of thrombosis management.
    Hawkins D
    Pharmacotherapy; 2004 Jul; 24(7 Pt 2):95S-99S. PubMed ID: 15317405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fondaparinux sodium.
    Reverter JC
    Drugs Today (Barc); 2002 Mar; 38(3):185-94. PubMed ID: 12532174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux versus enoxaparin for prevention of venous.
    Thaler H; Sim E
    Lancet; 2002 Nov; 360(9345):1604; author reply 1605. PubMed ID: 12443627
    [No Abstract]   [Full Text] [Related]  

  • 17. Fondaparinux versus enoxaparin for prevention of venous thromboembolism.
    Borja J; Olivella P; Curto J
    Lancet; 2002 Nov; 360(9345):1603-4; author reply 1605. PubMed ID: 12443626
    [No Abstract]   [Full Text] [Related]  

  • 18. Fondaparinux versus enoxaparin for prevention of venous.
    Morris E
    Lancet; 2002 Nov; 360(9345):1604-5; author reply 1605. PubMed ID: 12443628
    [No Abstract]   [Full Text] [Related]  

  • 19. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
    Turpie AG; Bauer KA; Eriksson BI; Lassen MR;
    Lancet; 2002 May; 359(9319):1721-6. PubMed ID: 12049860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
    Turpie AG; Eriksson BI; Lassen MR; Bauer KA
    J South Orthop Assoc; 2002; 11(4):182-8. PubMed ID: 12597061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.